CHIPS+
Optimising the health of young people with HIV in their transition from paediatric to adult care
The aim of the CHIPS+ cohort was to evaluate the longer-term health outcomes of young people in adult care who have HIV acquired in childhood
What was this study about?
Due to improvements in HIV treatment and care, increasing numbers of children living with HIV are surviving into adulthood and transitioning from paediatric to adult care. Nevertheless, data collection in CHARS (Children’s HIV and AIDS Reporting System), a secure online reporting surveillance service coordinated by the Integrated Screening Outcomes Surveillance Service (ISOSS) team ceases at the time of transfer to adult care. Thus, there is a substantial knowledge gap about long-term health outcomes of this group in the UK and Ireland, and worldwide; the CHIPS+ study aimed to bridge this gap by continuing to investigate the long-term health of young people living with HIV.
Young people in CHIPS+ consented to having their data linked to NHS England's Demographics, Cancer Registrations, and Civil Registration (Deaths) data sets, to obtain routinely collected data of the CHIPS+ cohort for long-term health outcomes, and to estimate the incidence of cancers and deaths.
What difference did this study make?
We have not started analysing the NHS England data yet but will begin to do this in 2025.
Type of study
Observational study
Contact details
Who funded the study?
CHIPS+ is linked to CHIPS and is funded via participation in European ART safety studies, themselves funded by pharmaceutical companies.
When did it take place?
July 2017 to December 2020
Where did it take place?
NHS clinics across the UK and Ireland
Who was included?
Patients aged ≥15 years who received paediatric HIV care in the UK or Ireland.